| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.009 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |